Le Lézard
Classified in: Health, Science and technology
Subject: Product/Service

Early Adopter Health Organizations, ?Achieving Impact Through Adoption of Innovative Health Technologies: Establishing Early Adopter Health Organizations as an Accelerator for Economic Growth in Ontario' - an OBIO Report


The Ontario Bioscience Innovation Organization (OBIO®) today released its latest report, ?Achieving Impact Through Adoption of Innovative Health Technologies: Establishing Early Adopter Health Organizations as an Accelerator for Economic Growth in Ontario', which describes an early adopter model to facilitate the evaluation and adoption of innovative health technologies in Ontario health organizations.

The report is the result of a series of consultations with executive-level stakeholders from Ontario health organizations and industry, as well as representatives from government and other affiliate organizations.

Following a key recommendation in OBIO's report, ?Tackling the Anchor Company Challenge ? OBIO Leadership Summit (2017),' which highlighted the need for early adopter organizations in Ontario, the report provides a robust model for establishing, governing and supporting these organizations to best engage with innovators.

The report was launched at the Conference Board of Canada, Council on Innovation Procurement in Health Care meeting. OBIO CEO, Gail Garland, was joined by Arden Krystal, President and CEO of the Southlake Regional Health Centre, Jo-anne Marr, President & CEO of Markham Stouffville Hospital and Stefano Picone, Director of Finance of Conavi Medical.

"Today, it is clearer than ever that a model to support the early adoption of novel technologies is crucial if our health science industry is going to continue to commercialize life-saving products, create jobs and attract investment in Ontario. We are pleased to present the EAHN model as a way to achieve these benefits," said Gail Garland, President and CEO, OBIO.

Overview of the Report:

To read ?Achieving Impact Through Adoption of Innovative Health Technologies: Establishing Early Adopter Health Organizations as an Accelerator for Economic Growth in Ontario,' please click here.

The Ontario Bioscience Innovation Organization (OBIO®) founded in 2009, is a not-for-profit, membership-based organization engaged in strategy, programming, policy development and advocacy to further the commercialization of Ontario's human health technologies positioning Ontario as a leader in the international marketplace. OBIO advances this goal through collaborative partnerships with industry, the investment community, academia, the health system and government.

For more information please visit www.obio.ca and follow OBIO on Twitter @OBIOscience.


These press releases may also interest you

at 00:30
The U.S. Patent and Trademark Office (USPTO) has awarded a new patent to the University of California (UC), University of Vienna, and Dr. Emmanuelle Charpentier covering methods of producing a genetically modified cell through the introduction of the...

15 jui 2019
Altaire Pharmaceuticals, Inc., announces today that it is voluntarily recalling the Prescription (RX) and Over-the-Counter  drug products and lots, within expiry, sold by OCuSOFT during the time period as indicated in the tables below. As a...

15 jui 2019
Heliae Development LLC, a leading Arizona biotechnology company with a world vision in which microalgae plays a vital role in supporting healthy life, hired Norm Davy as chief revenue officer and Lon Kreger as senior director, international sales....

15 jui 2019
South Texas Orthodontics is the newest affiliated practice to join the Dental Care Alliance Family, with four offices in and around San Antonio, Texas. Serving patients in La Cantera, Tezel (NW), Schertz and Stone Oak, South Texas Orthodontics is led...

15 jui 2019
Hurricane experts believe the City of New Orleans, Louisiana dodged a bullet when the Tropical Storm Barry failed to develop into a major hurricane as predicted, but a Houston, TX emergency room physician says that should serve as a warning to all...

15 jui 2019
Clinical Pathology Laboratories, Inc. ("CPL") has been informed by Retrieval Masters Creditors Bureau d/b/a American Medical Collection Agency ("AMCA") of a data security incident involving the AMCA payment website.  AMCA is an independent collection...



News published on 17 april 2019 at 13:00 and distributed by: